CN114886984A - Medicine for treating hyperosteogeny - Google Patents

Medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN114886984A
CN114886984A CN202210388866.9A CN202210388866A CN114886984A CN 114886984 A CN114886984 A CN 114886984A CN 202210388866 A CN202210388866 A CN 202210388866A CN 114886984 A CN114886984 A CN 114886984A
Authority
CN
China
Prior art keywords
medicine
treating
hyperosteogeny
blood
dragon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210388866.9A
Other languages
Chinese (zh)
Inventor
赵峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210388866.9A priority Critical patent/CN114886984A/en
Publication of CN114886984A publication Critical patent/CN114886984A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285Aucklandia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716Clematis (leather flower)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicine preparations, and provides a medicine for treating hyperosteogeny, which comprises dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5, also comprises radix Angelicae sinensis, rhizoma Ligustici Chuanxiong, Carthami flos, herba Saussureae Involueratae, herba Speranskiae Tuberculatae, herba Lycopodii, and Siegesbeckiae herba. By adopting the technical scheme, the problems of relatively poor curative effect and low cure rate of the medicine for treating the hyperosteogeny in the prior art are solved.

Description

Medicine for treating hyperosteogeny
Technical Field
The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a medicine for treating hyperosteogeny.
Background
Hyperosteogeny refers to the formation of osteophytes in the joints or spine, commonly known as "bone spur", which is usually caused by the high mobility and heavy loads in the cervical, lumbar, sacral, knee, heel, etc. With the age, the elasticity of the articular cartilage of a human is weakened, cartilage collagen fibers are exposed, the middle part of the joint is easy to wear when moving, the peripheral cartilage surface is subjected to metabolic proliferation and hypertrophy, and finally ossification is carried out to form bone spurs. Occupational permanent exertion, long-term body position badness, chronic or mechanical stimulation, traumatic injury and the like are important causes of diseases.
The treatment methods of the hyperosteogeny comprise operation treatment, acupuncture treatment, direct current medicine iontophoresis, massage and traction, traditional Chinese medicine therapy and the like. The surgical treatment is to excise the focus through the operation, but has very strict requirements on the indication and is easy to relapse; acupuncture therapy can promote menstruation and blood circulation, diminish inflammation and relieve pain, but cannot radically cure the diseases; the direct current drug ion introduction method is that drug ions are poured in under the action of current, but the poured drug is liquid and is volatile, and the drug effect is not lasting; the massage and traction are helpful for improving local blood circulation, diminishing inflammation and relieving pain, and relieving the pressure of the bony spur on local nerves and tissues, but the pain can be only temporarily relieved, and the radical treatment can not be realized; the traditional Chinese medical treatment law is to use medicines for diseases, exerts curative effect through strong penetration of medicines, has lasting effect, is simple and easy to implement, and has no side effect, but the existing medicines for treating hyperosteogeny have relatively poor curative effect and low cure rate.
Disclosure of Invention
The invention provides a medicament for treating hyperosteogeny, which solves the problems of relatively poor curative effect and low cure rate of the medicaments for treating the hyperosteogeny in the prior art.
The technical scheme of the invention is as follows:
the medicine for treating the hyperosteogeny is characterized by comprising dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5.
as a further technical proposal, the medicine also comprises angelica, Szechuan lovage rhizome, safflower and snow lotus.
As a further technical scheme, the traditional Chinese medicine also comprises garden balsam stem, common clubmoss herb and siegesbeckia orientalis.
As a further technical scheme, the mass ratio of the angelica, the ligusticum wallichii, the safflower, the snow lotus and the dragon's blood is (1-1.5): 2: (1-1.5): (1-1.5): 1.
as a further technical scheme, the mass ratio of the garden balsam stem, the lycopodium clavatum, the siegesbeckia orientalis to the dragon's blood is 2.5: 2: 2: 1.5.
the application method of the medicine for treating hyperosteogeny comprises the following steps: spraying rice vinegar onto towel, placing into metal support, collecting 20g medicinal powder, adding equal amount of tincture of rhizoma Zingiberis recens or alcohol, igniting, and fumigating focus joint for 15-20 min.
The working principle and the beneficial effects of the invention are as follows:
1. in the invention, the medicine for treating the hyperosteogeny mainly uses clematis root and is supplemented with dragon's blood, so that the medicine has the effects of activating blood circulation to dissipate blood stasis, softening hardness and dissipating stagnation, the prepared monkshood has the effects of dredging channels and activating collaterals, and relieving pain, and the astragalus root has the effects of tonifying qi and strengthening exterior, when in use, the prepared medicine enters the body through fumigation, penetrates through the skin, directly reaches focuses through the powerful penetration effect of the medicine, improves the local blood circulation, diminishes inflammation and relieves pain, and inhibits the growth of bony spur, and the cure rate of the medicine for patients with the hyperosteogeny reaches more than 93.5 percent through clinical verification.
2. According to the invention, on the basis of dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, angelica, ligusticum wallichii, safflower and saussurea involucrate are added, so that the blood circulation is promoted and the blood stasis is removed, and the treatment effect on the hyperosteogeny is further improved.
3. In the invention, based on the dragon's blood, the astragalus, the clematis root, the yam and the prepared aconite, the garden balsam stem, the lycopodium clavatum and the siegesbeckia orientalis are added to dredge the channels and activate the collaterals, thereby further improving the treatment effect on the hyperosteogeny.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any inventive step, are intended to be within the scope of the present invention.
Example 1
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima into a leaching solution, adding 1kg of fine dragon blood powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicament for treating the hyperosteogeny.
Example 2
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing an extraction solution from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 1kg of angelica, 2kg of ligusticum wallichii, 1kg of safflower and 1.5kg of saussurea involucrata into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicine for treating hyperosteogeny.
Example 3
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing extraction liquid from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 1.5kg of angelica, 2k g ligusticum wallichii, 1.5kg of safflower, 1kg of saussurea involucrate, 2.5kg of garden balsam stem, 2kg of lycopodium clavatum and 2kg of herba siegesbeckiae into coarse powder, mixing the coarse powder with the premix, uniformly mixing, drying and bagging to obtain the medicament for treating the hyperosteogeny.
Example 4
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing leaching solution from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 2.5kg of garden balsam stem, 2kg of lycopodium clavatum and 2kg of herba siegesbeckiae into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicine for treating hyperosteogeny.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (5)

1. The medicine for treating the hyperosteogeny is characterized by comprising dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5.
2. the medicament for treating hyperosteogeny according to claim 1, further comprising Chinese angelica, chuanxiong rhizome, safflower and snow lotus.
3. The medicine for treating hyperosteogeny according to claim 1 or 2, further comprising speranskia herb, lycopodium clavatum and siegesbeckia orientalis.
4. The medicament for treating the hyperosteogeny according to claim 2, wherein the mass ratio of the angelica, the Szechuan lovage rhizome, the safflower, the snow lotus and the dragon's blood is (1-1.5): 2: (1-1.5): (1-1.5): 1.
5. the medicine for treating hyperosteogeny according to claim 3, wherein the mass ratio of said speranskia herb, lycopodium clavatum, siegesbeckia orientalis to said dragon's blood is 2.5: 2: 2: 1.
CN202210388866.9A 2022-04-13 2022-04-13 Medicine for treating hyperosteogeny Pending CN114886984A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210388866.9A CN114886984A (en) 2022-04-13 2022-04-13 Medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210388866.9A CN114886984A (en) 2022-04-13 2022-04-13 Medicine for treating hyperosteogeny

Publications (1)

Publication Number Publication Date
CN114886984A true CN114886984A (en) 2022-08-12

Family

ID=82717233

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210388866.9A Pending CN114886984A (en) 2022-04-13 2022-04-13 Medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN114886984A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148971A (en) * 1996-09-17 1997-05-07 赵胜堂 Medicine for hyperosteogeny

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148971A (en) * 1996-09-17 1997-05-07 赵胜堂 Medicine for hyperosteogeny

Similar Documents

Publication Publication Date Title
CN104288538A (en) Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster
CN107397949A (en) A kind of ointment for treating neck-shoulder pain, lumbago and leg pain and preparation method thereof
CN1156048A (en) Jingyaoning medicine and its preparing method
CN101653565A (en) Traditional Chinese medicament externally applying paste for treating intervertebral disc protrusion
WO2006059853A1 (en) Composition having effect of moxibustion and press pellet using the same
CN110638987A (en) Moxibustion medicinal moxibustion stick for dispelling cold and eliminating dampness and preparation method thereof
CN105477783A (en) Traditional Chinese medicine transdermal introduction plate electrode and physiotherapy instrument for treating cervical vertebra, lumbar vertebra and joint aches
CN1539476A (en) Plaster for treating bone disease
CN102397515A (en) Plaster for treating rheumatic diseases
CN110743000A (en) Traditional Chinese medicine composition for acupoint application wet application and preparation method and using method thereof
CN101249179B (en) Medicine for external application for curing hyperosteogeny and disc herniation and method of preparing the same
CN101244135B (en) Medicine label for treating rheumatism, hyperosteogeny
CN103893298A (en) Chinese herbal medicine rhizoma drynariae plaster and preparation method thereof
CN114886984A (en) Medicine for treating hyperosteogeny
CN1064245C (en) Medicine for hyperosteogeny
CN114306436A (en) A Chinese medicinal composition cataplasma for treating osteoarticular pain and preparation method thereof
CN101530598B (en) Plaster used for hyperosteogeny
CN112121086A (en) A Chinese medicinal tincture for transdermal therapy and its preparation method
CN104721040A (en) Far infrared moxibustion plaster based on traditional Chinese medicine components
CN1069046C (en) Liniment for treating bony spur
CN103721183B (en) A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia
CN103028021A (en) Traditional Chinese medicine for treating osteomyelitis and preparation method thereof
CN102349949A (en) Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica
CN105560537A (en) Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN107456500B (en) Preparation method of Chinese herbal medicine moxibustion plaster for adjuvant therapy of neck, shoulder, waist and leg pain

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220812

RJ01 Rejection of invention patent application after publication